Table 1.
Characteristics of the study population (n = 536).
| Men | Women | P value | ||
|---|---|---|---|---|
| N = 441 | N = 95 | |||
| Age [years] | < .001 | |||
| < 40 | 3 (0.7) | 0 (0.0) | ||
| 40–49 | 13 (2.9) | 3 (3.2) | ||
| 50–59 | 72 (16.3) | 14 (14.7) | ||
| 60–69 | 165 (37.4) | 32 (33.7) | ||
| 70–79 | 169 (38.3) | 36 (37.9) | ||
| ≥ 80 | 19 (4.3) | 10 (10.5) | ||
| Cardiovascular event/procedure | < .001 | |||
| CABG1 | 73 (16.6) | 10 (10.5) | ||
| PTCA1 | 310 (70.3) | 60 (63.2) | ||
| Acute myocardial infarction | 17 (3.9) | 11 (11.6) | ||
| Acute myocardial ischemia | 41 (9.3) | 14 (14.7) | ||
| Duration of coronary artery disease [years] | .139 | |||
| < 10 | 324 (74.3) | 78 (83.9) | ||
| 10–19 | 73 (16.7) | 9 (9.7) | ||
| ≥ 20 | 39 (8.9) | 6 (6.5) | ||
| Hypertension [yes] | 217 (52.2) | 49 (57.6) | .356 | |
| Dysglycemia | .402 | |||
| Diabetes mellitus | 174 (39.5) | 33 (34.7) | ||
| Impaired glucose tolerance | 45 (10.2) | 12 (12.6) | ||
| Impaired fasting glucose | 83 (18.8) | 16 (16.8) | ||
| Unknown | 39 (8.8) | 14 (14.7) | ||
| Dyslipidemia [yes] | 370 (89.4) | 81 (89.0) | .920 | |
| Smoking status | .005 | |||
| Never smoker | 136 (30.8) | 46 (48.4) | ||
| Ex-smoker | 257 (58.3) | 41 (43.2) | ||
| Smoker | 48 (10.9) | 8 (8.4) | ||
| Central obesity [yes] | 262 (60.1) | 71 (76.3) | .003 | |
| Antihypertensive therapy | 423 (95.9) | 94 (98.9) | .336 | |
| Antihyperglycemic therapy | 77 (17.5) | 12 (12.6) | .004 | |
| Treatment of dyslipidemia | .814 | |||
| Any drug | 376 (85.3) | 82 (86.3) | ||
| Statin therapy | 366 (83.8) | 80 (84.2) |
Data are frequency (percent).
CABG coronary artery bypass graft, PTCA percutaneous transluminal coronary angioplasty.
1Elective/emergency intervention.